Topic
Recovery & Tissue Research
Quick answers
- What is it?
- This hub covers what the research actually shows about healing and rebuilding soft tissue — muscle, tendon, ligament, and bone — after injury, disuse, or surgery, and about the treatments and compounds people use to try to speed that process up, from everyday habits like sleep and stretching to popular research peptides like BPC-157 and TB-500.
- Why are people interested in it?
- Anyone recovering from a strain, tendon problem, fracture, or period of inactivity wants to know which recovery methods are backed by real evidence and which are popular online but essentially untested in people.
- What has actually been studied?
- The sources span human randomized trials and meta-analyses on collagen, PRP (platelet-rich plasma), stem cell injections, cold water immersion, curcumin, NSAIDs, stretching, sleep, blood flow restriction training, and fracture and tendinopathy treatments, alongside peptides — BPC-157, TB-500, GHK-Cu, IGF-1 LR3, ipamorelin, follistatin, and LL-37 — where most of the available evidence comes from rats, mice, or small early-phase studies rather than large human trials.
- How strong is the evidence?
- It varies enormously by topic: PRP, collagen, sleep-injury links, and loaded exercise for tendinopathy all have real human randomized trials and meta-analyses, though results within each are often mixed or split; BPC-157, TB-500, IGF-1 LR3, and GHK-Cu, despite their popularity, rest almost entirely on animal and cell-culture data, with essentially no completed human trials testing what they're marketed for.
- What don't we know yet?
- For the popular research peptides, it's largely unknown whether animal healing effects translate to humans at all, since no human trial has tested BPC-157 or TB-500 for tendon or muscle healing and no safe or effective human dose has ever been established; for the better-studied approaches, open questions include why collagen builds tendon size without always improving strength, why stem cell therapy improves pain but not joint structure, and how long benefits from any of these interventions actually last.
- Where can I read the original research?
- See the individual articles on BPC-157, TB-500, collagen, PRP, stem cell injections, cold water immersion, sleep, and tendinopathy treatments in this hub, plus the peptide profiles for BPC-157, TB-500, GHK-Cu, IGF-1 LR3, ipamorelin, follistatin, and LL-37 for the full source-by-source breakdown.
BPC-157 and TB-500 are among the most talked-about peptides for injury and tissue repair, and almost all of that evidence is from animals. This hub covers what has been tested in people for tendon, muscle, bone and wound healing, alongside the mainstream comparisons: rest, loading, PRP, NSAIDs and sleep.
Peptides in the Evidence Index
Research on this topic
Video briefs
Frequently asked
Does BPC-157 have any real human evidence for tendon or muscle healing?
Almost none. A 2025 scoping review found the entire human clinical evidence base for BPC-157 limited to three small pilot studies — on knee pain, interstitial cystitis, and intravenous safety — and none of them tested tendon or muscle. The one verifiable tendon-specific human trial ever registered (a 2015 Phase 1 study in 42 healthy volunteers) is still listed as 'Unknown' status and has never reported results. Everything showing BPC-157 speeds tendon or muscle repair comes from rat studies, mostly from a single research group in Zagreb, Croatia.
Does TB-500 (thymosin beta-4) actually help tendons heal?
No human trial has ever tested TB-500 — the short fragment actually sold online — for anything. The only ClinicalTrials.gov record naming 'TB-500' states in its own summary that it is 'a fictional study... an example of a ClinicalTrials.gov-style record.' The related full-length protein, thymosin beta-4, does have 18 registered human trials, but they studied heart attacks, dry eye, corneal wounds, and pressure ulcers — not tendons, ligaments, or muscle. The entire evidence tying TB-500 to tendon repair is a single 2026 rat study of 32 animals.
Do collagen peptides actually help muscle, tendons, or joint pain?
The evidence is genuinely split. For muscle, a 2015 trial found sarcopenic men gained more fat-free mass with collagen than placebo, and a 2024 meta-analysis of 19 trials found small-to-moderate benefits — but a controlled feeding study found collagen, unlike whey or pea protein, produced no measurable increase in muscle protein synthesis. For tendons, collagen reliably increased Achilles tendon size in one 14-week trial (+11.0% vs +4.7% for placebo), but didn't improve tendon stiffness or strength in that trial, and a separate 15-week trial found no tendon benefit on any measure. For joint pain, an 11-trial meta-analysis of 870 people found collagen improved both pain and function versus placebo, but when tested head-to-head against exercise therapy in athletes with early knee arthritis, exercise — not collagen — did most of the measurable work.
How long does soft tissue actually take to heal?
Much longer than symptoms suggest, and it varies a lot by tissue type. General soft tissue healing runs through an inflammatory phase and a proliferative phase lasting days to a few weeks, then a remodeling phase that unfolds over months. Even after remodeling, a classic review notes healed tendon's biochemical and mechanical properties never fully match intact tendon. Ligament graft tissue takes longest: human ACL reconstruction biopsies still showed significantly different cell counts and collagen structure from native ligament more than 9 years after surgery. Severity matters too — one pilot study found simple ankle sprains returned athletes to play in a mean of 26 days versus 91 days for a high ankle sprain, and a cohort following ligament reconstruction surgery found a mean return-to-sport time of 172 days.
Which tendinopathy treatments have the strongest evidence?
Progressive loading exercise comes out on top. A 2026 network meta-analysis of patellar tendinopathy found no intervention — including blood flow restriction training or eccentric-only protocols — statistically beat heavy slow resistance training across 10 pooled trials, and a separate network meta-analysis of hip tendinopathy found exercise therapy the single most effective conservative option across 19 trials and 1,701 patients. Corticosteroid injections give real short-term pain relief for tennis elbow but no significant advantage over placebo past 12 weeks. Extracorporeal shockwave therapy fared worst in the newest review, showing no clinically meaningful benefit over sham. PRP's evidence is site-dependent — ranked most likely to help shoulder calcific tendinopathy in one network meta-analysis, but rated only 'moderate' for tennis elbow in another.
Do stem cell injections or PRP actually work for joint or tendon injury?
Both show real but mixed effects, and almost all the evidence covers chronic conditions rather than acute injury. Stem cell (MSC) injections are studied almost exclusively in knee osteoarthritis; pain improves fairly consistently across meta-analyses, but a broader 2026 meta-analysis of 28 trials found overall function, quality of life, and MRI-based joint structure did not improve, concluding the therapy looks 'symptom-modifying rather than structure-modifying,' with local reactions like joint swelling more common than with control. For PRP, the largest sham-controlled trial ever run (240 patients with chronic Achilles tendinopathy) found no meaningful benefit over a fake injection, and a 2022 meta-analysis of 33 trials across six tendon conditions found PRP beat comparators in only one, carpal tunnel syndrome — but PRP used as a surgical adjunct during rotator cuff repair lowered the retear rate from 25.4% to 19.3% in a 17-trial meta-analysis.
New to this?
Start here for plain-English explanations of clinical trials, evidence levels, and how to read a study.